GemVax&KAEL Revenue

GemVax&KAEL had revenue of 17.98B KRW in the quarter ending September 30, 2025, with 41.16% growth. This brings the company's revenue in the last twelve months to 73.64B, up 17.39% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.

Revenue (ttm)

73.64B

Revenue Growth

+17.39%

P/S Ratio

18.60

Revenue / Employee

404.62M

Employees

182

Market Cap

1,369.58B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%
Dec 31, 2020	65.66B	23.00B	53.91%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	315.56T
SK hynix	84.09T
LG Energy Solution	23.98T
Samsung Biologics	5,504.84B
Hyundai Motor Company	186.04T
Doosan Enerbility	16.79T
Kia Corporation	113.20T
HD Hyundai Heavy Industries	16.39T

Revenue Rankings